Column Group II GP, LP, 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 732 shares at $17.99 ($13K) on 2020-07-30, disclosed to the SEC on 2020-08-03.
Open-market purchase of $13k NGM by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| Filing → |
| NGM | BUY | 2019-07-15 | $885K | — | Filing → |
| NGM | BUY | 2019-05-09 | $804K | — | Filing → |
| IMDZ | BUY | 2016-09-22 | $5.0M | — | Filing → |